{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:52:43Z","timestamp":1787496763430,"version":"build-2736575974"},"reference-count":39,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD), the second most prevalent neurodegenerative disease, is closely linked to aging and immune system dysfunction. This study aims to explore potential aging-related biomarkers of PD and examine their diagnostic value, in addition to their relationship with immune cell infiltration, to identify novel therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Gene expression profiles from the gene expression omnibus (GEO) database (GSE20163, GSE20164, and GSE8397) were analyzed. Aging-related genes associated with PD were screened using weighted gene co-expression network analysis. Subsequent functional enrichment analysis, protein\u2012protein interaction (PPI) network mapping, and least absolute shrinkage and selection operator regression were used to identify key biomarker candidates. A receiver operating characteristic (ROC) curve analysis was applied to evaluate diagnostic efficacy. Immune cell infiltration was assessed through Spearman correlation analysis, and the expression of key biomarkers was validated in both cellular and animal PD models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Eighteen aging-related genes were identified through a PPI network analysis. Seven genes, including forkhead box O3 (FOXO3) and the proto-oncogene tyrosine-protein kinase receptor rearranged during transfection (RET), showed potential as diagnostic biomarkers for PD. Gene set enrichment analysis revealed that these biomarkers correlated with immune cell infiltration patterns in PD patients. The ROC curve analysis indicated high diagnostic accuracy for these genes across multiple datasets (area under the curve = 96.3158).\n                      <jats:italic>In vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      validation confirmed significant changes in the expression of RET and FOXO3 in PD samples, highlighting their relevance as biomarkers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings suggest that RET and FOXO3 are promising aging-related biomarkers for PD, potentially providing new insights into the early diagnosis and targeted treatment of PD. These biomarkers also reflect the complex interplay between aging, immunity, and PD pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/cytojournal_127_2025","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:58:49Z","timestamp":1781783929000},"page":"38","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioinformatics identification of forkhead box O3 and the proto-oncogene tyrosine-protein kinase receptor RET as aging-associated biomarkers linked to immune cell infiltration in Parkinson\u2019s disease"],"prefix":"10.25259","volume":"23","author":[{"given":"Haoran","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Neurology, Tongji University School of Medicine, Shanghai Tenth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Health, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Medicine, Shanghai University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"10.25259\/Cytojournal_127_2025\/ref-1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"GBD 2016 Parkinson's Disease Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-3","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","article-title":"Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation","volume":"2016","author":"Magrinelli","year":"2016","journal-title":"Parkinsons Dis"},{"key":"10.25259\/Cytojournal_127_2025\/ref-4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20080295","article-title":"Protein stability and aggregation in Parkinson's disease","volume":"413","author":"Robinson","year":"2008","journal-title":"Biochem J"},{"key":"10.25259\/Cytojournal_127_2025\/ref-5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.25259\/Cytojournal_127_2025\/ref-6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.dadm.2019.01.011","article-title":"Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System","volume":"11","author":"Van Eimeren","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.25259\/Cytojournal_127_2025\/ref-7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson's disease: Different sides of the same coin?","volume":"32","author":"Collier","year":"2017","journal-title":"Mov Disord"},{"key":"10.25259\/Cytojournal_127_2025\/ref-9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.25259\/Cytojournal_127_2025\/ref-10","doi-asserted-by":"publisher","first-page":"100982","DOI":"10.1016\/j.arr.2019.100982","article-title":"Ageing, age-related diseases and oxidative stress: What to do next?","volume":"57","author":"Luo","year":"2020","journal-title":"Ageing Res Rev"},{"key":"10.25259\/Cytojournal_127_2025\/ref-11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.neurobiolaging.2005.03.013","article-title":"mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging","volume":"27","author":"Frank","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.25259\/Cytojournal_127_2025\/ref-12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"s1","key":"10.25259\/Cytojournal_127_2025\/ref-13","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.3233\/JPD-179003","article-title":"The identification of alpha-synuclein as the first Parkinson disease gene","volume":"7","author":"Nussbaum","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.25259\/Cytojournal_127_2025\/ref-14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","article-title":"T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an a-synuclein rat model of Parkinson's disease","volume":"17","author":"Subbarayan","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.25259\/Cytojournal_127_2025\/ref-15","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: What we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"10.25259\/Cytojournal_127_2025\/ref-16","doi-asserted-by":"publisher","first-page":"eadm8563","DOI":"10.1126\/scitranslmed.adm8563","article-title":"Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"16","author":"Bido","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.25259\/Cytojournal_127_2025\/ref-17","doi-asserted-by":"publisher","first-page":"572090","DOI":"10.3389\/fnagi.2020.572090","article-title":"Aging and neurodegenerative disease: Is the adaptive immune system a friend or foe?","volume":"12","author":"Mayne","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-18","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1016\/j.csbj.2022.09.018","article-title":"Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson's disease","volume":"20","author":"Jian","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.25259\/Cytojournal_127_2025\/ref-19","doi-asserted-by":"publisher","first-page":"948615","DOI":"10.3389\/fimmu.2022.948615","article-title":"Identification and validation of key molecules associated with humoral immune modulation in Parkinson's disease based on bioinformatics","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-21","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkx1042","article-title":"Human ageing genomic resources: New and updated databases","volume":"46","author":"Tacutu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.25259\/Cytojournal_127_2025\/ref-22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: An R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.25259\/Cytojournal_127_2025\/ref-23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape stringapp: Network analysis and visualization of proteomics data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J Proteome Res"},{"key":"10.25259\/Cytojournal_127_2025\/ref-24","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: A unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.25259\/Cytojournal_127_2025\/ref-25","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1007\/s11033-021-06430-w","article-title":"Lithium inhibits oxidative stress-induced neuronal senescence through miR-34a","volume":"48","author":"Tufekci","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.25259\/Cytojournal_127_2025\/ref-26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2020.00016","article-title":"Cellular senescence in neurodegenerative diseases","volume":"14","author":"Mart\u00ednez-Cu\u00e9","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-28","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-29","doi-asserted-by":"publisher","first-page":"648636","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: A target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.25259\/Cytojournal_127_2025\/ref-31","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.3390\/ijms23147726","article-title":"The role of neurotrophin signaling in age-related cognitive decline and cognitive diseases","volume":"23","author":"Numakawa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.25259\/Cytojournal_127_2025\/ref-32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-020-03227-4","article-title":"Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease","volume":"382","author":"Mahato","year":"2020","journal-title":"Cell Tissue Res"},{"key":"10.25259\/Cytojournal_127_2025\/ref-33","doi-asserted-by":"publisher","first-page":"105298","DOI":"10.1016\/j.nbd.2021.105298","article-title":"GDNF signaling in subjects with minimal motor deficits and Parkinson's disease","volume":"153","author":"Chu","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.25259\/Cytojournal_127_2025\/ref-34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","article-title":"Large-scale proteomic analyses of incident Parkinson's disease reveal new pathophysiological insights and potential biomarkers","volume":"5","author":"Gan","year":"2025","journal-title":"Nat Aging"},{"key":"10.25259\/Cytojournal_127_2025\/ref-35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4103\/1673-5374.327330","article-title":"Is activation of GDNF\/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic","volume":"17","author":"Conway","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.25259\/Cytojournal_127_2025\/ref-36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1326-4-32","article-title":"Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease","volume":"4","author":"Su","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.25259\/Cytojournal_127_2025\/ref-37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/hmg\/ddt530","article-title":"FOXO3 determines the accumulation of a-synuclein and controls the fate of dopaminergic neurons in the substantia nigra","volume":"23","author":"Pino","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.25259\/Cytojournal_127_2025\/ref-38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2024.02.018","article-title":"Revealing novel genes related to Parkinson's disease pathogenesis and establishing an associated model","volume":"544","author":"Deng","year":"2024","journal-title":"Neuroscience"},{"key":"10.25259\/Cytojournal_127_2025\/ref-39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat Rev Drug Discov"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/bioinformatics-identification-of-forkhead-box-o3-and-the-proto-oncogene-tyrosine-protein-kinase-receptor-ret-as-aging-associated-biomarkers-linked-to-immune-cell-infiltration-in-parkinsons-dis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/bioinformatics-identification-of-forkhead-box-o3-and-the-proto-oncogene-tyrosine-protein-kinase-receptor-ret-as-aging-associated-biomarkers-linked-to-immune-cell-infiltration-in-parkinsons-dis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:58:50Z","timestamp":1781783930000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/bioinformatics-identification-of-forkhead-box-o3-and-the-proto-oncogene-tyrosine-protein-kinase-receptor-ret-as-aging-associated-biomarkers-linked-to-immune-cell-infiltration-in-parkinsons-dis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":39,"alternative-id":["10.25259\/Cytojournal_127_2025"],"URL":"https:\/\/doi.org\/10.25259\/cytojournal_127_2025","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"38"}}